ATE101854T1 - Spirocyclische antipsychotische mittel. - Google Patents

Spirocyclische antipsychotische mittel.

Info

Publication number
ATE101854T1
ATE101854T1 AT90202012T AT90202012T ATE101854T1 AT E101854 T1 ATE101854 T1 AT E101854T1 AT 90202012 T AT90202012 T AT 90202012T AT 90202012 T AT90202012 T AT 90202012T AT E101854 T1 ATE101854 T1 AT E101854T1
Authority
AT
Austria
Prior art keywords
sychotic
spirocyclic
agents
spiro
piperidine
Prior art date
Application number
AT90202012T
Other languages
English (en)
Inventor
David Charles Billington
Mark Stuart Chambers
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE101854T1 publication Critical patent/ATE101854T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
AT90202012T 1989-07-26 1990-07-23 Spirocyclische antipsychotische mittel. ATE101854T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917069A GB8917069D0 (en) 1989-07-26 1989-07-26 Therapeutic agents

Publications (1)

Publication Number Publication Date
ATE101854T1 true ATE101854T1 (de) 1994-03-15

Family

ID=10660644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90202012T ATE101854T1 (de) 1989-07-26 1990-07-23 Spirocyclische antipsychotische mittel.

Country Status (17)

Country Link
EP (1) EP0414289B1 (de)
JP (1) JPH03184959A (de)
KR (1) KR910002444A (de)
AT (1) ATE101854T1 (de)
AU (1) AU628612B2 (de)
CA (1) CA2021736A1 (de)
DE (1) DE69006799T2 (de)
DK (1) DK0414289T3 (de)
ES (1) ES2062303T3 (de)
FI (1) FI903728A7 (de)
GB (1) GB8917069D0 (de)
IE (1) IE902706A1 (de)
IL (1) IL95124A0 (de)
NO (1) NO903315L (de)
NZ (1) NZ234557A (de)
PT (1) PT94806A (de)
ZA (1) ZA905841B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445974A3 (en) * 1990-03-05 1992-04-29 Merck Sharp & Dohme Ltd. Spirocyclic antipsychotic agents
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
WO1994007496A1 (en) * 1992-10-07 1994-04-14 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5670509A (en) * 1993-09-27 1997-09-23 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
WO1995028389A1 (en) * 1994-04-15 1995-10-26 Yamanouchi Pharmaceutical Co., Ltd. Spiro compound and medicinal composition thereof
JP2003513006A (ja) * 1999-06-07 2003-04-08 ワーナー−ランバート・カンパニー 三環性鎮痛薬
US7045527B2 (en) 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
CA2558585C (en) 2004-02-27 2010-10-12 Amgen Inc. Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
US7786141B2 (en) 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
EP2374455A3 (de) * 2004-08-19 2012-03-28 Vertex Pharmaceuticals Incorporated Modulatoren von muskarinischen Rezeptoren
SI1781618T1 (sl) 2004-08-27 2013-01-31 Laboratorios Del Dr. Esteve, S.A. Inhibitorji sigma receptorja
CA2576144C (en) 2004-08-27 2012-12-11 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
ATE520668T1 (de) 2004-08-27 2011-09-15 Esteve Labor Dr Sigmarezeptor-inhibitoren
EP1634873A1 (de) 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Sigmarezeptor-Inhibitoren
RU2007124373A (ru) 2004-11-29 2009-01-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Модуляторы мускариновых рецептеров
EP1924546A1 (de) 2005-09-14 2008-05-28 Amgen, Inc Konformationseingeschränkte 3- (4-hydroxy-phenyl) substitutierte propansäuren zur behandlung von stoffwechselstörungen
AU2006330866A1 (en) 2005-12-22 2007-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
KR20080098070A (ko) 2006-02-22 2008-11-06 버텍스 파마슈티칼스 인코포레이티드 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘
AU2007221214A1 (en) 2006-02-22 2007-09-07 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
JP2009528315A (ja) * 2006-03-01 2009-08-06 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ シグマ受容体阻害剤としてのピラゾール誘導体
EP1829875A1 (de) 2006-03-01 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Pyrazolderivate als Inhibitoren des Sigma-Rezeptors
EP1829866A1 (de) 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Inhibitoren von Sigmarezeptoren
EP1829867A1 (de) 2006-03-03 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Gegenüber dem Sigmarezeptor pharmazeutisch aktive Imidazolverbindungen
CN101500565A (zh) 2006-06-29 2009-08-05 弗特克斯药品有限公司 毒蕈碱性受体的调节剂
AU2007284548A1 (en) 2006-08-15 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
CA2660974A1 (en) 2006-08-18 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
CA2662242C (en) 2006-09-07 2012-06-12 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
EP2064193A1 (de) 2006-09-07 2009-06-03 Amgen, Inc Heterozyklische gpr40-modulatoren
AU2008241490B2 (en) 2007-04-16 2011-07-21 Amgen Inc. Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid GPR40 modulators
JP2010540640A (ja) 2007-10-03 2010-12-24 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン作用性レセプターのモジュレーター
US8030354B2 (en) 2007-10-10 2011-10-04 Amgen Inc. Substituted biphenyl GPR40 modulators
WO2009111056A1 (en) 2008-03-06 2009-09-11 Amgen Inc. Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
EP2116539A1 (de) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-Aryl-3-Amino-alkoxy-pyrazole als Sigma-Liganden zur Verbesserung der analgetischen Wirkung von Opioiden und zur Schwächung der Abhängigkeit davon
AU2009303475B2 (en) 2008-10-15 2012-09-13 Amgen Inc. Spirocyclic GPR40 modulators
EP2353598A1 (de) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Anwendung in der Vorbeugung und/oder Behandlung von postoperativem Schmerz
EP2353591A1 (de) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Verstärkung der analgesischen Wirkung von Opioden und Opiaten bei postoperativem Schmerz und zur Schwächung der Abhängigkeit davon
EP2388005A1 (de) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Vorbeugung und/oder Behandlung von Erbrechen infolge von Chemotherapie oder Strahlentherapie
EP2395003A1 (de) 2010-05-27 2011-12-14 Laboratorios Del. Dr. Esteve, S.A. Pyrazolverbindungen als Sigmarezeptor-Inhibitoren
EP2415471A1 (de) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Sigmaliganden bei opioidinduzierter Hyperalgesie
EP2524694A1 (de) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Sigmaliganden bei Schmerz im Zusammenhang mit Typ-2-Diabetes
TN2016000228A1 (en) 2013-12-17 2017-10-06 Esteve Labor Dr SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides

Also Published As

Publication number Publication date
AU5984490A (en) 1991-01-31
JPH03184959A (ja) 1991-08-12
GB8917069D0 (en) 1989-09-13
EP0414289A1 (de) 1991-02-27
IL95124A0 (en) 1991-06-10
PT94806A (pt) 1991-03-20
FI903728A7 (fi) 1991-01-27
DE69006799D1 (de) 1994-03-31
AU628612B2 (en) 1992-09-17
NO903315L (no) 1991-01-28
CA2021736A1 (en) 1991-01-27
FI903728A0 (fi) 1990-07-25
ZA905841B (en) 1991-06-26
DE69006799T2 (de) 1994-08-11
ES2062303T3 (es) 1994-12-16
NO903315D0 (no) 1990-07-25
KR910002444A (ko) 1991-02-25
IE902706A1 (en) 1991-02-27
NZ234557A (en) 1992-12-23
DK0414289T3 (da) 1994-04-11
EP0414289B1 (de) 1994-02-23

Similar Documents

Publication Publication Date Title
ATE101854T1 (de) Spirocyclische antipsychotische mittel.
DE69022567D1 (de) Polycarbonat-polydimethylsiloxan copolymer und herstellungsverfahren.
DE69014357D1 (de) Fahrzeug-Steuervorrichtung und Steuerverfahren.
DE68905846D1 (de) Gesaettigte laugen zur behandlung von bohrloechern und additive dafuer.
DE69203928D1 (de) Fahrzeugmontageverfahren und Fahrzeugkarosserie.
DE68912148D1 (de) Fahrzeug-Wechselstromgenerator und Herstellungsverfahren.
DE69000467D1 (de) Bis-aza-bicyclische anxiolytica und antidepressiva.
DE3886557D1 (de) Kraftfahrzeugaufhängung mit regelbarer Vorrichtung und Regelvorrichtung dafür.
ATE47853T1 (de) 5,6-difluornaphtyridine und 5,6,8trifluorchinoline verwendbar als antibakterielle mittel.
DE58900363D1 (de) Vorrichtung zum aufrichten und aufreihen von formteilen.
DE69002528D1 (de) Bremse mit selbsttaetig nachstellender oeffnung und verschleissnachstellvorrichtung.
DE69003548D1 (de) Transparente schweisshemmende mittel und herstellungsverfahren.
EP0410535A3 (de) Octahydrobenzisochinolin-Derivate als antipsychotische Mittel
DE69637363D1 (de) 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2 on-derivate mit pde iv und cytokin-inhibirendes aktivität
DE3887345D1 (de) Fluoriertes copolymer und sperrschichten.
DE68908037D1 (de) Polyaetherimid-mischungen und formverfahren.
DE68921157D1 (de) Aufzeichnungskopf und Aufzeichnungsvorrichtung, die damit versehen ist.
ATA242390A (de) Vorrichtung zum arretieren von toren und dgl.
DE3853296D1 (de) Blätterverteilungsverfahren und vorrichtung.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ATE69235T1 (de) Erythromycin-a-derivate, modifiziert in position- c-12.
ATE100094T1 (de) Imidazolantiarrythmische mittel.
DE59001699D1 (de) Vorrichtung zum querschneiden und querschweissen von bahnen.
DE3769329D1 (de) Alpha-(2-alkoxyphenyl)-alpha-alkyl-1h-1,2,4-triazol-1-propannitrile und derivate.
DE68919512D1 (de) Chinoxalin-Derivate und antiulzerierendes Mittel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee